Remove 2020 Remove Individual Remove Management Remove Provider
article thumbnail

"Survival Mode": Experiences of moral distress in Canadian primary care professionals during and after the COVID-19 pandemic [COVID-19]

Annals of Family Medicine

Objective: This project explored the presence, nature, and effects of moral distress in Canadian primary healthcare professionals from two provinces during (March 2020-May 2023) and after the COVID-19 pandemic. Intervention/Instrument: Individual semi-structured interviews and review of pertinent case-relevant documents.

article thumbnail

Approaches for Quelling Stigma related to COVID-19

BMJ

A multilayered view of stigmatizing discourses lays the foundation for eliciting a series of suggestions for quelling stigma, to be implemented at the individual, community, and national levels, as suggested by the WHO. Int J Soc Psychiatry 2020 (May 21; published online). Front Commun ́2020 (June 12; published online).

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Episode 148: Antiracism in Medicine Series Episode 4 – Dismantling Race-Based Medicine Part 2: Clinical Perspectives

The Clinical Problem Solvers

Moreover, center patients not only in discussions about individual decision-making but in constructing and drawing meaning from the research. However, the diagnostic approach used to determine changes in clinical management of renal disease (i.e. September 8, 2020. Published online May 11, 2020. 2016 Jul;91(7):916-20.

Clinic 52
article thumbnail

Episode 282: Anti-Racism in Medicine Series – Episode 20 – Medical Racism and Indigenous Peoples

The Clinical Problem Solvers

The dehumanization of individuals of color at the margins of society by the healthcare system is not simply a thing of the past, and is certainly a persistent phenomenon. Cindy Gladue, Brian Sinclair, and Joyce Echaquan are three Indigenous individuals who suffered immense harm at the hands of the healthcare system.

Medical 52
article thumbnail

FDA Draft Guidance: Everything You May Want to Know about OMUFA Fees

FDA Law Blog

The draft guidance provides information regarding various aspects of the OMUFA program under sections 744L and 744M of the FDC Act, as added by the CARES Act. FDA stresses that the law does not provide exemptions or waivers. By Riëtte van Laack & Deborah L. Livornese — Early Nov.

article thumbnail

Deprescribing Super Special Part II: Podcast with Elizabeth Bayliss, Ariel Green, and Kevin McConeghy

GeriPal

My take home from this is that while the most preferred explanation for deprescribing statins and sedative-hypnotics is one focused on the risk of side effects, we also need to individualize it to the patient and the medication that they are taking. Maybe that’s where the individualizing it, the person that’s front of me.

article thumbnail

Change is Inevitable – Plan Ahead: An Assessment of FDA’s Draft Guidance on Predetermined Change Control Plans for Artificial Intelligence/Machine Learning-Enabled Device Software Functions

FDA Law Blog

The discussion paper described a PCCP as including (1) the types of anticipated modifications (SaMD Pre-Specifications or SPS) based on the retraining and model update strategy and (2) the associated methodology (Algorithm Change Protocol or ACP) being used to implement those changes in a controlled manner to manage patient risks.